Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.06 | 0.7 |